Business Context and Reporting Period
Park Ha Biological Technology Co., Ltd. filed Form 6-K for the month of December 2025, reporting on the results of its 2025 Extraordinary General Meeting held on December 26, 2025, in Wuxi, China. The filing details shareholder approvals regarding capital structure changes and corporate governance amendments.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate actions and voting results.
Material Changes and Corporate Actions
- Share Capital Increase: Shareholders approved an increase in share capital by US$2,700,000. The total authorized capital will be US$3,000,000, divided into 150,000,000,000 ordinary shares (120 billion Class A and 30 billion Class B) with a par value of US$0.00002 each.
- Share Consolidation: Shareholders approved a share consolidation with a ratio ranging from 1-for-5 to 1-for-250. The exact ratio and effective date are to be determined by the Board of Directors within one year of the record date (November 21, 2025). Fractional shares will be rounded up.
- Governance Amendments: The Company's Amended and Restated Memorandum and Articles of Association were approved to reflect the capital changes.
Voting Results
| Matter | For | Against | Abstain |
|---|---|---|---|
| Increase of Share Capital | 383,634,298 | 344,106 | 4,135 |
| Amendment of Articles of Association | 383,634,093 | 344,312 | 4,135 |
| Share Consolidation | 383,710,490 | 268,949 | 3,100 |
Quorum Status: A quorum was reached with 2,982,543 Class A shares and 19,050,000 Class B shares present or represented by proxy out of the total issued and outstanding shares.
Outlook and Risks
The filing does not provide management commentary, financial guidance, or specific risk factors. The primary contingency noted is the Board's discretion to determine the specific share consolidation ratio and effective date within the approved range and timeframe.
Investor Verification Checklist
- Verify the exact share consolidation ratio and effective date once announced by the Board.
- Confirm the impact of the share consolidation on the number of shares held and the par value per share.
- Review the full text of the New Amended and Restated Memorandum and Articles of Association (Exhibit 3.1) for detailed governance changes.
- Monitor future filings for the actual issuance of shares related to the approved capital increase.